Loading…

In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death

The in vitro activity against Leishmania spp. of a novel group of compounds, phenalenone derivatives, is described in this study. Previous studies have shown that some phenalenones present leishmanicidal activity, and induce a decrease in the mitochondrial membrane potential in L. amazonensis parasi...

Full description

Saved in:
Bibliographic Details
Published in:Parasites & vectors 2019-12, Vol.12 (1), p.601-601, Article 601
Main Authors: López-Arencibia, Atteneri, Reyes-Batlle, María, Freijo, Mónica B, Sifaoui, Ines, Bethencourt-Estrella, Carlos J, Rizo-Liendo, Aitor, Chiboub, Olfa, McNaughton-Smith, Grant, Lorenzo-Morales, Jacob, Abad-Grillo, Teresa, Piñero, José E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The in vitro activity against Leishmania spp. of a novel group of compounds, phenalenone derivatives, is described in this study. Previous studies have shown that some phenalenones present leishmanicidal activity, and induce a decrease in the mitochondrial membrane potential in L. amazonensis parasites, so in order to elucidate the evidence of programmed cell death occurring inside the promastigote stage, different assays were performed in two different species of Leishmania. We focused on the determination of the programmed cell death evidence by detecting the characteristic features of the apoptosis-like process, such as phosphatidylserine exposure, mitochondrial membrane potential, and chromatin condensation among others. The results showed that four molecules activated the apoptosis-like process in the parasite. All the signals observed were indicative of the death process that the parasites were undergoing. The present results highlight the potential use of phenalenone derivatives against Leishmania species and further studies should be undertaken to establish them as novel leishmanicidal therapeutic agents.
ISSN:1756-3305
1756-3305
DOI:10.1186/s13071-019-3854-4